小規模バイオリアクターの市場規模、シェア、動向分析レポート：製品別、容量別、最終用途別、地域別、セグメント予測、2025～2033年

小規模バイオリアクター市場の成長と動向：

Grand View Research, Inc.の最新レポートによると、世界の小規模バイオリアクターの市場規模は2033年までに24億9,000万米ドルに達し、2025～2033年までのCAGRは9.4％を記録すると推定されています。

この製品は需要が高く、COVID-19のパンデミックの結果、市場は急成長すると予測されています。パンデミックは細胞ベースの創薬研究の必要性を高め、また人口規模に応じた新薬やワクチンの製造需要も高めています。例えば、世界保健機関（WHO）の2022年版報告書によると、COVID-19の大流行を受けてワクチン研究はかつてないペースに加速し、2022年4月4日現在、世界中で約112億5,000万回分のワクチンが接種されています。

さらに、上流処理、並列処理、バイオプロセス最適化のための実験評価における小規模バイオプロセスシステムの使用は、プロセス開発における小規模バイオリアクターの需要を促進すると予想されます。COVID-19の結果、バイオプロセス技術産業の収益は増加しています。したがって、すべての主要サプライヤーによれば、SARS-CoV-2ワクチンの開発は急速に進展しています。さらに、ワクチン研究開発の増加に伴い、バイオプロセス技術の需要も伸びています。例えば、2020年7月、PallとCytivaの親会社であるDanaherは、第2四半期の純利益が26％増加し、売上高が19％増加したと報告しました。同様に、Sartorius Stedim Biotechもパンデミックの恩恵を受けています。同社の上半期の売上高は18％増の10億5,000万米ドルでした。

同社幹部はCOVID-19への要望を主な原動力として挙げています。さらに、小規模バイオリアクターの旺盛な需要は、複数のバイオテクノロジー企業や製薬企業の間でCOVID-19関連の研究開発が最近活発化していることが背景にあります。さらに、予測期間中の市場の成長は、バイオプロセスのための技術開発と装置設計の進歩の上昇によって促進されます。また、小規模バイオリアクターの売上は、複数のメーカーによる製品発表の増加や製品ラインの拡充の結果、増加すると予想されます。例えば、2022年10月、Foilaboは、完全に自動化されたラボスケールバイオプロセスシステムの新しいコレクションを発表することにより、温度制御実験装置の製品ラインを拡大しました。

小規模バイオリアクター市場レポートのハイライト

• 製品別では、再利用可能バイオリアクターセグメントが予測期間中に大きく成長すると予測されています。これは、製薬およびバイオ医薬品業界では、コスト効率の高い製造のために再利用可能バイオリアクターのニーズが高いためです。
• 容量別では、1L～3Lのバイオリアクターが小規模生産で広く利用可能であるため、2024年にはこのセグメントが最大の収益シェアを占めました。
• 最終用途別では、CRO・CMOセグメントは、2024年に最大のシェアを占めました。これらの企業は、治療薬メーカーよりも使い捨てバイオリアクターの新規導入が早かったため、より大きな収益シェアに貢献しています。
• 北米は、2024年の地域別市場において支配的でした。これは、複数のグローバル企業の存在と、この地域におけるプロテオミクスおよびライフサイエンス研究のための公的機関および民間機関からの投資の増加によるものです。

目次

第1章 調査手法と範囲

第2章 エグゼクティブサマリー

第3章 市場の変数、動向、範囲

• 市場セグメンテーションと範囲
• 市場系統の展望
  • 親市場の展望
  • 関連/補助市場展望
• 市場力学
  • 市場促進要因分析
  • 市場抑制要因分析
• 業界分析ツール
  • SWOT分析：要因別（政治・法律、経済、技術）
  • ポーターのファイブフォース分析

第4章 小規模バイオリアクター市場：製品別のビジネス分析

• 小規模バイオリアクター市場：製品別の市場シェア分析
• 製品別
• 再利用可能バイオリアクター
• 使い捨てバイオリアクター

第5章 小規模バイオリアクター市場：容量別のビジネス分析

• 小規模バイオリアクター市場：容量別の市場シェア分析
• 容量別
• 5ML～100ML
• 100ML～250ML
• 250ML～500ML
• 500ML～1L
• 1L～3L
• 3L～5L

第6章 小規模バイオリアクター市場：最終用途別のビジネス分析

• 小規模バイオリアクター市場：最終用途別の市場シェア分析
• 最終用途別
• 製薬・バイオ医薬品企業
• CRO・CMO
• 学術研究機関

第7章 小規模バイオリアクター市場：地域別のビジネス分析

• 小規模バイオリアクター市場シェア（地域別）、2024年および2033年
• 北米
• 欧州
• アジア太平洋
• ラテンアメリカ
• 中東・アフリカ

第8章 競合情勢

• 企業分類
• 戦略マッピング
• 企業プロファイル/上場企業
  • Sartorius AG
  • Thermo Fisher Scientific Inc.
  • Merck KGaA
  • Danaher Corporation
  • LAMBDA Instruments GmbH
  • Solida Biotech GmbH
  • Getinge AB
  • DONALDSON ITALIA SRL（Solaris Biotechnology Srl）
  • Eppendorf AG
  • Infors AG

List of Tables

• Table 1 List of secondary sources
• Table 2 List of abbreviations
• Table 3 Global small-scale bioreactors market, by product, 2021 - 2033 (USD Million)
• Table 4 Global small-scale bioreactors market, by capacity, 2021 - 2033 (USD Million)
• Table 5 Global small-scale bioreactors market, by end use, 2021 - 2033 (USD Million)
• Table 6 Global small-scale bioreactors market, by region, 2021 - 2033 (USD Million)
• Table 7 North America small-scale bioreactors market, by country, 2021 - 2033 (USD Million)
• Table 8 North America small-scale bioreactors market, by product, 2021 - 2033 (USD Million)
• Table 9 North America small-scale bioreactors market, by capacity, 2021 - 2033 (USD Million)
• Table 10 North America small-scale bioreactors market, by end use, 2021 - 2033 (USD Million)
• Table 11 U.S. small-scale bioreactors market, by product, 2021 - 2033 (USD Million)
• Table 12 U.S. small-scale bioreactors market, by capacity, 2021 - 2033 (USD Million)
• Table 13 U.S. small-scale bioreactors market, by end use, 2021 - 2033 (USD Million)
• Table 14 Canada small-scale bioreactors market, by product, 2021 - 2033 (USD Million)
• Table 15 Canada small-scale bioreactors market, by capacity, 2021 - 2033 (USD Million)
• Table 16 Canada small-scale bioreactors market, by end use, 2021 - 2033 (USD Million)
• Table 17 Mexico small-scale bioreactors market, by product, 2021 - 2033 (USD Million)
• Table 18 Mexico small-scale bioreactors market, by capacity, 2021 - 2033 (USD Million)
• Table 19 Mexico small-scale bioreactors market, by end use, 2021 - 2033 (USD Million)
• Table 20 Europe small-scale bioreactors market, by country, 2021 - 2033 (USD Million)
• Table 21 Europe small-scale bioreactors market, by product, 2021 - 2033 (USD Million)
• Table 22 Europe small-scale bioreactors market, by capacity, 2021 - 2033 (USD Million)
• Table 23 Europe small-scale bioreactors market, by end use, 2021 - 2033 (USD Million)
• Table 24 UK small-scale bioreactors market, by product, 2021 - 2033 (USD Million)
• Table 25 UK small-scale bioreactors market, by capacity, 2021 - 2033 (USD Million)
• Table 26 UK small-scale bioreactors market, by end use, 2021 - 2033 (USD Million)
• Table 27 Germany small-scale bioreactors market, by product, 2021 - 2033 (USD Million)
• Table 28 Germany small-scale bioreactors market, by capacity, 2021 - 2033 (USD Million)
• Table 29 Germany small-scale bioreactors market, by end use, 2021 - 2033 (USD Million)
• Table 30 France small-scale bioreactors market, by product, 2021 - 2033 (USD Million)
• Table 31 France small-scale bioreactors market, by capacity, 2021 - 2033 (USD Million)
• Table 32 France small-scale bioreactors market, by end use, 2021 - 2033 (USD Million)
• Table 33 Italy small-scale bioreactors market, by product, 2021 - 2033 (USD Million)
• Table 34 Italy small-scale bioreactors market, by capacity, 2021 - 2033 (USD Million)
• Table 35 Italy small-scale bioreactors market, by end use, 2021 - 2033 (USD Million)
• Table 36 Spain small-scale bioreactors market, by product, 2021 - 2033 (USD Million)
• Table 37 Spain small-scale bioreactors market, by capacity, 2021 - 2033 (USD Million)
• Table 38 Spain small-scale bioreactors market, by end use, 2021 - 2033 (USD Million)
• Table 39 Denmark small-scale bioreactors market, by product, 2021 - 2033 (USD Million)
• Table 40 Denmark small-scale bioreactors market, by capacity, 2021 - 2033 (USD Million)
• Table 41 Denmark small-scale bioreactors market, by end use, 2021 - 2033 (USD Million)
• Table 42 Sweden small-scale bioreactors market, by product, 2021 - 2033 (USD Million)
• Table 43 Sweden small-scale bioreactors market, by capacity, 2021 - 2033 (USD Million)
• Table 44 Sweden small-scale bioreactors market, by end use, 2021 - 2033 (USD Million)
• Table 45 Norway small-scale bioreactors market, by product, 2021 - 2033 (USD Million)
• Table 46 Norway small-scale bioreactors market, by capacity, 2021 - 2033 (USD Million)
• Table 47 Norway small-scale bioreactors market, by end use, 2021 - 2033 (USD Million)
• Table 48 Asia Pacific small-scale bioreactors market, by country, 2021 - 2033 (USD Million)
• Table 49 Asia Pacific small-scale bioreactors market, by product, 2021 - 2033 (USD Million)
• Table 50 Asia Pacific small-scale bioreactors market, by capacity, 2021 - 2033 (USD Million)
• Table 51 Asia Pacific small-scale bioreactors market, by end use, 2021 - 2033 (USD Million)
• Table 52 Japan small-scale bioreactors market, by product, 2021 - 2033 (USD Million)
• Table 53 Japan small-scale bioreactors market, by capacity, 2021 - 2033 (USD Million)
• Table 54 Japan small-scale bioreactors market, by end use, 2021 - 2033 (USD Million)
• Table 55 China small-scale bioreactors market, by product, 2021 - 2033 (USD Million)
• Table 56 China small-scale bioreactors market, by capacity, 2021 - 2033 (USD Million)
• Table 57 China small-scale bioreactors market, by end use, 2021 - 2033 (USD Million)
• Table 58 India small-scale bioreactors market, by product, 2021 - 2033 (USD Million)
• Table 59 India small-scale bioreactors market, by capacity, 2021 - 2033 (USD Million)
• Table 60 India small-scale bioreactors market, by end use, 2021 - 2033 (USD Million)
• Table 61 Australia small-scale bioreactors market, by product, 2021 - 2033 (USD Million)
• Table 62 Australia small-scale bioreactors market, by capacity, 2021 - 2033 (USD Million)
• Table 63 Australia small-scale bioreactors market, by end use, 2021 - 2033 (USD Million)
• Table 64 Thailand small-scale bioreactors market, by product, 2021 - 2033 (USD Million)
• Table 65 Thailand small-scale bioreactors market, by capacity, 2021 - 2033 (USD Million)
• Table 66 Thailand small-scale bioreactors market, by end use, 2021 - 2033 (USD Million)
• Table 67 South Korea small-scale bioreactors market, by product, 2021 - 2033 (USD Million)
• Table 68 South Korea small-scale bioreactors market, by capacity, 2021 - 2033 (USD Million)
• Table 69 South Korea small-scale bioreactors market, by end use, 2021 - 2033 (USD Million)
• Table 70 Latin America small-scale bioreactors market, by country, 2021 - 2033 (USD Million)
• Table 71 Latin America small-scale bioreactors market, by product, 2021 - 2033 (USD Million)
• Table 72 Latin America small-scale bioreactors market, by capacity, 2021 - 2033 (USD Million)
• Table 73 Latin America small-scale bioreactors market, by end use, 2021 - 2033 (USD Million)
• Table 74 Brazil small-scale bioreactors market, by product, 2021 - 2033 (USD Million)
• Table 75 Brazil small-scale bioreactors market, by capacity, 2021 - 2033 (USD Million)
• Table 76 Brazil small-scale bioreactors market, by end use, 2021 - 2033 (USD Million)
• Table 77 Argentina small-scale bioreactors market, by product, 2021 - 2033 (USD Million)
• Table 78 Argentina small-scale bioreactors market, by capacity, 2021 - 2033 (USD Million)
• Table 79 Argentina small-scale bioreactors market, by end use, 2021 - 2033 (USD Million)
• Table 80 Middle East & Africa small-scale bioreactors market, by country, 2021 - 2033 (USD Million)
• Table 81 Middle East & Africa small-scale bioreactors market, by product, 2021 - 2033 (USD Million)
• Table 82 Middle East & Africa small-scale bioreactors market, by capacity, 2021 - 2033 (USD Million)
• Table 83 Middle East & Africa small-scale bioreactors market, by end use, 2021 - 2033 (USD Million)
• Table 84 South Africa small-scale bioreactors market, by product, 2021 - 2033 (USD Million)
• Table 85 South Africa small-scale bioreactors market, by capacity, 2021 - 2033 (USD Million)
• Table 86 South Africa small-scale bioreactors market, by end use, 2021 - 2033 (USD Million)
• Table 87 Saudi Arabia small-scale bioreactors market, by product, 2021 - 2033 (USD Million)
• Table 88 Saudi Arabia small-scale bioreactors market, by capacity, 2021 - 2033 (USD Million)
• Table 89 Saudi Arabia small-scale bioreactors market, by end use, 2021 - 2033 (USD Million)
• Table 90 UAE small-scale bioreactors market, by product, 2021 - 2033 (USD Million)
• Table 91 UAE small-scale bioreactors market, by capacity, 2021 - 2033 (USD Million)
• Table 92 UAE small-scale bioreactors market, by end use, 2021 - 2033 (USD Million)
• Table 93 Kuwait small-scale bioreactors market, by product, 2021 - 2033 (USD Million)
• Table 94 Kuwait small-scale bioreactors market, by capacity, 2021 - 2033 (USD Million)
• Table 95 Kuwait small-scale bioreactors market, by end use, 2021 - 2033 (USD Million)

List of Figures

• Fig. 1 Small-scale bioreactors market segmentation
• Fig. 2 Market research process
• Fig. 3 Data triangulation techniques
• Fig. 4 Primary research pattern
• Fig. 5 Market research approaches
• Fig. 6 Value-chain-based sizing & forecasting
• Fig. 7 QFD modeling for market share assessment
• Fig. 8 Market formulation & validation
• Fig. 9 Market snapshot
• Fig. 10 Segment snapshot
• Fig. 11 Competitive landscape snapshot
• Fig. 12 Parent market outlook
• Fig. 13 Related/ancillary market outlook
• Fig. 14 Small-scale bioreactors - Industry value chain analysis
• Fig. 15 Small-scale bioreactors market driver analysis
• Fig. 16 Small-scale bioreactors market restraint analysis
• Fig. 17 Small-scale bioreactors market: Porter's analysis
• Fig. 18 Small-scale bioreactors market: PESTLE analysis
• Fig. 19 Small-scale bioreactors market: Product outlook and key takeaways
• Fig. 20 Small-scale bioreactors market: Product market share analysis, 2021 - 2033
• Fig. 21 Global Reusable Bioreactors market, 2021 - 2033 (USD Million)
• Fig. 22 Global Stainless Steel Bioreactors market, 2021 - 2033 (USD Million)
• Fig. 23 Global Glass Bioreactors market, 2021 - 2033 (USD Million)
• Fig. 24 Global Single-use Bioreactors market, 2021 - 2033 (USD Million)
• Fig. 25 Small-scale bioreactors market: Capacity outlook and key takeaways
• Fig. 26 Small-scale bioreactors market: Capacity market share analysis, 2021 - 2033
• Fig. 27 Global 5 ML -100 ML market, 2021 - 2033 (USD Million)
• Fig. 28 Global 100 ML-250 ML market, 2021 - 2033 (USD Million)
• Fig. 29 Global 250 ML -500 ML market, 2021 - 2033 (USD Million)
• Fig. 30 Global 500 ML-1 L market, 2021 - 2033 (USD Million)
• Fig. 31 Global 1L-3L market, 2021 - 2033 (USD Million)
• Fig. 32 Global 3L-5L market, 2021 - 2033 (USD Million)
• Fig. 33 Small-scale bioreactors market: End use outlook and key takeaways
• Fig. 34 Small-scale bioreactors market: End use market share analysis, 2024 - 2033
• Fig. 35 Global Pharmaceutical & Biopharmaceutical Companies market, 2021 - 2033 (USD Million)
• Fig. 36 Global CROs & CMOs market, 2021 - 2033 (USD Million)
• Fig. 37 Global Academic & Research Institutes market, 2021 - 2033 (USD Million)
• Fig. 38 Regional marketplace: Key takeaways
• Fig. 39 Regional marketplace: Key takeaways
• Fig. 40 North America small-scale bioreactors market estimates and forecast, 2021 - 2033 (USD Million)
• Fig. 41 U.S. key country dynamics
• Fig. 42 U.S. small-scale bioreactors market estimates and forecast, 2021 - 2033 (USD Million)
• Fig. 43 Canada key country dynamics
• Fig. 44 Canada small-scale bioreactors market, 2021 - 2033 (USD Million)
• Fig. 45 Mexico key country dynamics
• Fig. 46 Mexico small-scale bioreactors market estimates and forecast, 2021 - 2033 (USD Million)
• Fig. 47 Europe small-scale bioreactors market estimates and forecast, 2021 - 2033 (USD Million)
• Fig. 48 UK key country dynamics
• Fig. 49 UK small-scale bioreactors market estimates and forecast, 2021 - 2033 (USD Million)
• Fig. 50 Germany key country dynamics
• Fig. 51 Germany small-scale bioreactors market estimates and forecast, 2021 - 2033 (USD Million)
• Fig. 52 France key country dynamics
• Fig. 53 France small-scale bioreactors market estimates and forecast, 2021 - 2033 (USD Million)
• Fig. 54 Italy key country dynamics
• Fig. 55 Italy small-scale bioreactors market estimates and forecast, 2021 - 2033 (USD Million)
• Fig. 56 Spain key country dynamics
• Fig. 57 Spain small-scale bioreactors market estimates and forecast, 2021 - 2033 (USD Million)
• Fig. 58 Denmark key country dynamics
• Fig. 59 Denmark small-scale bioreactors market estimates and forecast, 2021 - 2033 (USD Million)
• Fig. 60 Sweden key country dynamics
• Fig. 61 Sweden small-scale bioreactors market estimates and forecast, 2021 - 2033 (USD Million)
• Fig. 62 Norway key country dynamics
• Fig. 63 Norway small-scale bioreactors market estimates and forecast, 2021 - 2033 (USD Million)
• Fig. 64 Asia-Pacific small-scale bioreactors market estimates and forecast, 2021 - 2033 (USD Million)
• Fig. 65 Japan key country dynamics
• Fig. 66 Japan small-scale bioreactors market estimates and forecast, 2021 - 2033 (USD Million)
• Fig. 67 China key country dynamics
• Fig. 68 China small-scale bioreactors market estimates and forecast, 2021 - 2033 (USD Million)
• Fig. 69 India key country dynamics
• Fig. 70 India small-scale bioreactors market estimates and forecast, 2021 - 2033 (USD Million)
• Fig. 71 Australia key country dynamics
• Fig. 72 Australia small-scale bioreactors market estimates and forecast, 2021 - 2033 (USD Million)
• Fig. 73 Thailand key country dynamics
• Fig. 74 Thailand small-scale bioreactors market estimates and forecast, 2021 - 2033 (USD Million)
• Fig. 75 South Korea key country dynamics
• Fig. 76 South Korea small-scale bioreactors market estimates and forecast, 2021 - 2033 (USD Million)
• Fig. 77 Latin America small-scale bioreactors market estimates and forecast, 2021 - 2033 (USD Million)
• Fig. 78 Brazil key country dynamics
• Fig. 79 Brazil small-scale bioreactors market estimates and forecast, 2021 - 2033 (USD Million)
• Fig. 80 Argentina key country dynamics
• Fig. 81 Argentina small-scale bioreactors market estimates and forecast, 2021 - 2033 (USD Million)
• Fig. 82 MEA small-scale bioreactors market estimates and forecast, 2021 - 2033 (USD Million)
• Fig. 83 South Africa key country dynamics
• Fig. 84 South Africa small-scale bioreactors market estimates and forecast, 2021 - 2033 (USD Million)
• Fig. 85 Saudi Arabia key country dynamics
• Fig. 86 Saudi Arabia small-scale bioreactors market estimates and forecast, 2021 - 2033 (USD Million)
• Fig. 87 UAE key country dynamics
• Fig. 88 UAE small-scale bioreactors market estimates and forecast, 2021 - 2033 (USD Million)
• Fig. 89 Kuwait key country dynamics
• Fig. 90 Kuwait small-scale bioreactors market estimates and forecast, 2021 - 2033 (USD Million)
• Fig. 91 Key company categorization
• Fig. 92 Company market positioning
• Fig. 93 Market participant categorization
• Fig. 94 Strategy framework

Small-scale Bioreactors Market Growth & Trends:

The global small-scale bioreactors market size is estimated to reach USD 2.49 billion by 2033, registering a CAGR of 9.4% from 2025 to 2033, according to a new report by Grand View Research, Inc. The product has a high demand and the market is anticipated to grow rapidly as a result of the COVID-19 pandemic. The pandemic has increased the need for research on cell-based drug discovery and also the demand for manufacturing novel medicines and vaccines according to the size of the population. For instance, according to the World Health Organization's 2022 report, vaccine research has accelerated to an unprecedented pace in response to the COVID-19 pandemic and approximately 11.25 billion vaccine doses had been given around the globe as of 4 April 2022.

Moreover, the use of small-scale bioprocessing systems in upstream processing, parallel processing, and experiment evaluation for bioprocess optimization is expected to drive the demand for small-scale bioreactors in process development. Revenues in the bioprocessing technology industry have increased as a result of COVID-19. Thus, the development of a SARS-CoV-2 vaccine has progressed quickly, according to all major suppliers. In addition, the demand for bioprocessing technologies had also grown as a result of a rise in vaccine R&D. For instance, in July 2020, Danaher, the parent company of Pall and Cytiva, reported a 26% increase in net income and a 19% increase in second-quarter sales. Similarly, Sartorius Stedim Biotech also has benefited from the pandemic. The company's sales increased 18% to $1.05 billion in the first half of the year.

The desire for COVID-19 was cited by company executives as a key driver. Furthermore, the strong demand for small-scale bioreactors is being driven by the recent increase in COVID-19-related research and development between several biotech and pharmaceutical companies. Furthermore, the growth of the market during the forecast period is fueled by the rise in technical development and advancements in equipment design for bioprocessing. The sales of small-scale bioreactors are also expected to increase as a result of an increase in product launches and the expansion of product lines by several manufacturers. For instance, in October 2022, Froilabo expanded its line of temperature-controlled laboratory equipment by introducing a new collection of completely automated lab-scale bioprocessing systems.

Small-scale Bioreactors Market Report Highlights:

• Based on product, the reusable bioreactors segment is expected to grow significantly during the forecast period, owing to the higher need for reusable bioreactors in the pharmaceutical and biopharmaceutical industries for cost-effective manufacturing.
• The 1L-3L capacity segment accounted for the largest revenue share in 2024, due to the wide-scale availability of bioreactors with a working volume capacity of 1L-3L in small-scale production.
• The CROs & CMOs end-user segment held the largest share in 2024. Since these companies have adopted novel single-use bioreactors much more quickly than therapeutic manufacturers, they have contributed to a larger revenue share.
• North America was the dominant regional market in 2024, due to the presence of several global players and growing investments from public & private organizations for proteomic and life science research in the region.

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation and Scope
  • 1.1.1. Segment Definitions
    • 1.1.1.1. Product
    • 1.1.1.2. Capacity
    • 1.1.1.3. End Use
• 1.2. Research Methodology
• 1.3. Information Procurement
  • 1.3.1. Purchased Database
  • 1.3.2. GVR's Internal Database
  • 1.3.3. Secondary Sources
  • 1.3.4. Primary Research
• 1.4. Information or Data Analysis:
  • 1.4.1. Data Analysis Models
• 1.5. Market Formulation & Validation
• 1.6. Model Details
  • 1.6.1. Commodity Flow Analysis
• 1.7. List of Secondary Sources
• 1.8. List of Abbreviations

Chapter 2. Executive Summary

• 2.1. Market Snapshot
• 2.2. Segment Snapshot
• 2.3. Competitive Landscape Snapshot

Chapter 3. Market Variables, Trends, & Scope

• 3.1. Market Segmentation and Scope
• 3.2. Market Lineage Outlook
  • 3.2.1. Parent Market Outlook
  • 3.2.2. Related/Ancillary Market Outlook
• 3.3. Market Dynamics
  • 3.3.1. Market Driver Analysis
    • 3.3.1.1. Increasing research & development activities in the biopharmaceutical industry
    • 3.3.1.2. Highly competitive market and various strategies undertaken by market players
    • 3.3.1.3. Increasing demand for single-use small-scale bioreactors
  • 3.3.2. Market Restraint Analysis
    • 3.3.2.1. Limitations of small-scale bioreactors
• 3.4. Industry Analysis Tools
  • 3.4.1. SWOT Analysis: By Factor (Political & Legal, Economic, And Technological)
  • 3.4.2. Porter's Five Forces Analysis

Chapter 4. Small-Scale Bioreactors Market: Product Business Analysis

• 4.1. Small-Scale Bioreactors Market: Product Market Share Analysis
• 4.2. Small-Scale Bioreactors Market Estimates & Forecast, By Product (USD Million)
• 4.3. Reusable Bioreactors
  • 4.3.1. Global Reusable Bioreactors Market, 2021 - 2033 (USD Million)
  • 4.3.2. Stainless Steel Bioreactors
    • 4.3.2.1. Global Stainless Steel Bioreactors Market, 2021 - 2033 (USD Million)
  • 4.3.3. Glass Bioreactors
    • 4.3.3.1. Global Glass Bioreactors Market, 2021 - 2033 (USD Million)
• 4.4. Single-use Bioreactors
  • 4.4.1. Global Single-use Bioreactors Market, 2021 - 2033 (USD Million)

Chapter 5. Small-Scale Bioreactors Market: Capacity Business Analysis

• 5.1. Small-Scale Bioreactors Market: Capacity Market Share Analysis
• 5.2. Small-Scale Bioreactors Market Estimates & Forecast, By Capacity (USD Million)
• 5.3. 5 ML- 100 ML
  • 5.3.1. Global 5 ML - 100 ML Market, 2021 - 2033 (USD Million)
• 5.4. 100 ML - 250 ML
  • 5.4.1. Global 100 ML - 250 ML Market, 2021 - 2033 (USD Million)
• 5.5. 250 ML - 500 ML
  • 5.5.1. Global 250 ML - 500 ML Market, 2021 - 2033 (USD Million)
• 5.6. 500 ML - 1 L
  • 5.6.1. Global 500 ML - 1 L Market, 2021 - 2033 (USD Million)
• 5.7. 1 L - 3 L
  • 5.7.1. Global 1 L - 3 L Market, 2021 - 2033 (USD Million)
• 5.8. 3 L - 5 L
  • 5.8.1. Global 3 L - 5 L Market, 2021 - 2033 (USD Million)

Chapter 6. Small-Scale Bioreactors Market: End Use Business Analysis

• 6.1. Small-Scale Bioreactors Market: End Use Market Share Analysis
• 6.2. Small-Scale Bioreactors Market Estimates & Forecast, By End Use (USD Million)
• 6.3. Pharmaceutical & Biopharmaceutical Companies
  • 6.3.1. Global Pharmaceutical & Biopharmaceutical Companies Market, 2021 - 2033 (USD Million)
• 6.4. CROs & CMOs
  • 6.4.1. Global CROs & CMOs Market, 2021 - 2033 (USD Million)
• 6.5. Academic & Research Institutes
  • 6.5.1. Global Academic & Research Institutes Market, 2021 - 2033 (USD Million)

Chapter 7. Small-Scale Bioreactors Market: Regional Business Analysis

• 7.1. Small-Scale Bioreactors Market Share By Region, 2024 & 2033
• 7.2. North America
  • 7.2.1. North America Small-Scale Bioreactors Market, 2021 - 2033 (USD Million)
  • 7.2.2. U.S.
    • 7.2.2.1. Key Country Dynamics
    • 7.2.2.2. Competitive Scenario
    • 7.2.2.3. Regulatory Framework
    • 7.2.2.4. U.S. Small-Scale Bioreactors Market, 2021 - 2033 (USD Million)
  • 7.2.3. Canada
    • 7.2.3.1. Key Country Dynamics
    • 7.2.3.2. Competitive Scenario
    • 7.2.3.3. Regulatory Framework
    • 7.2.3.4. Canada Small-Scale Bioreactors Market, 2021 - 2033 (USD Million)
  • 7.2.4. Mexico
    • 7.2.4.1. Key Country Dynamics
    • 7.2.4.2. Competitive Scenario
    • 7.2.4.3. Regulatory Framework
    • 7.2.4.4. Mexico Small-Scale Bioreactors Market, 2021 - 2033 (USD Million)
• 7.3. Europe
  • 7.3.1. Europe Small-Scale Bioreactors Market, 2021 - 2033 (USD Million)
  • 7.3.2. UK
    • 7.3.2.1. Key Country Dynamics
    • 7.3.2.2. Competitive Scenario
    • 7.3.2.3. Regulatory Framework
    • 7.3.2.4. UK Small-Scale Bioreactors Market, 2021 - 2033 (USD Million)
  • 7.3.3. Germany
    • 7.3.3.1. Key Country Dynamics
    • 7.3.3.2. Competitive Scenario
    • 7.3.3.3. Regulatory Framework
    • 7.3.3.4. Germany Small-Scale Bioreactors Market, 2021 - 2033 (USD Million)
  • 7.3.4. France
    • 7.3.4.1. Key Country Dynamics
    • 7.3.4.2. Competitive Scenario
    • 7.3.4.3. Regulatory Framework
    • 7.3.4.4. France Small-Scale Bioreactors Market, 2021 - 2033 (USD Million)
  • 7.3.5. Italy
    • 7.3.5.1. Key Country Dynamics
    • 7.3.5.2. Competitive Scenario
    • 7.3.5.3. Regulatory Framework
    • 7.3.5.4. Italy Small-Scale Bioreactors Market, 2021 - 2033 (USD Million)
  • 7.3.6. Spain
    • 7.3.6.1. Key Country Dynamics
    • 7.3.6.2. Competitive Scenario
    • 7.3.6.3. Regulatory Framework
    • 7.3.6.4. Spain Small-Scale Bioreactors Market, 2021 - 2033 (USD Million)
  • 7.3.7. Denmark
    • 7.3.7.1. Key Country Dynamics
    • 7.3.7.2. Competitive Scenario
    • 7.3.7.3. Regulatory Framework
    • 7.3.7.4. Denmark Small-Scale Bioreactors Market, 2021 - 2033 (USD Million)
  • 7.3.8. Sweden
    • 7.3.8.1. Key Country Dynamics
    • 7.3.8.2. Competitive Scenario
    • 7.3.8.3. Regulatory Framework
    • 7.3.8.4. Sweden Small-Scale Bioreactors Market, 2021 - 2033 (USD Million)
  • 7.3.9. Norway
    • 7.3.9.1. Key Country Dynamics
    • 7.3.9.2. Competitive Scenario
    • 7.3.9.3. Regulatory Framework
    • 7.3.9.4. Norway Small-Scale Bioreactors Market, 2021 - 2033 (USD Million)
• 7.4. Asia Pacific
  • 7.4.1. Asia Pacific Small-Scale Bioreactors Market, 2021 - 2033 (USD Million)
  • 7.4.2. Japan
    • 7.4.2.1. Key Country Dynamics
    • 7.4.2.2. Competitive Scenario
    • 7.4.2.3. Regulatory Framework
    • 7.4.2.4. Japan Small-Scale Bioreactors Market, 2021 - 2033 (USD Million)
  • 7.4.3. China
    • 7.4.3.1. Key Country Dynamics
    • 7.4.3.2. Competitive Scenario
    • 7.4.3.3. Regulatory Framework
    • 7.4.3.4. China Small-Scale Bioreactors Market, 2021 - 2033 (USD Million)
  • 7.4.4. India
    • 7.4.4.1. Key Country Dynamics
    • 7.4.4.2. Competitive Scenario
    • 7.4.4.3. Regulatory Framework
    • 7.4.4.4. India Small-Scale Bioreactors Market, 2021 - 2033 (USD Million)
  • 7.4.5. Australia
    • 7.4.5.1. Key Country Dynamics
    • 7.4.5.2. Competitive Scenario
    • 7.4.5.3. Regulatory Framework
    • 7.4.5.4. Australia Small-Scale Bioreactors Market, 2021 - 2033 (USD Million)
  • 7.4.6. Thailand
    • 7.4.6.1. Key Country Dynamics
    • 7.4.6.2. Competitive Scenario
    • 7.4.6.3. Regulatory Framework
    • 7.4.6.4. Thailand Small-Scale Bioreactors Market, 2021 - 2033 (USD Million)
  • 7.4.7. South Korea
    • 7.4.7.1. Key Country Dynamics
    • 7.4.7.2. Competitive Scenario
    • 7.4.7.3. Regulatory Framework
    • 7.4.7.4. South Korea Small-Scale Bioreactors Market, 2021 - 2033 (USD Million)
• 7.5. Latin America
  • 7.5.1. Latin America Small-Scale Bioreactors Market, 2021 - 2033 (USD Million)
  • 7.5.2. Brazil
    • 7.5.2.1. Key Country Dynamics
    • 7.5.2.2. Competitive Scenario
    • 7.5.2.3. Regulatory Framework
    • 7.5.2.4. Brazil Small-Scale Bioreactors Market, 2021 - 2033 (USD Million)
  • 7.5.3. Argentina
    • 7.5.3.1. Key Country Dynamics
    • 7.5.3.2. Competitive Scenario
    • 7.5.3.3. Regulatory Framework
    • 7.5.3.4. Argentina Small-Scale Bioreactors Market, 2021 - 2033 (USD Million)
• 7.6. MEA
  • 7.6.1. MEA Small-Scale Bioreactors Market, 2021 - 2033 (USD Million)
  • 7.6.2. South Africa
    • 7.6.2.1. Key Country Dynamics
    • 7.6.2.2. Competitive Scenario
    • 7.6.2.3. Regulatory Framework
    • 7.6.2.4. South Africa Small-Scale Bioreactors Market, 2021 - 2033 (USD Million)
  • 7.6.3. Saudi Arabia
    • 7.6.3.1. Key Country Dynamics
    • 7.6.3.2. Competitive Scenario
    • 7.6.3.3. Regulatory Framework
    • 7.6.3.4. Saudi Arabia Small-Scale Bioreactors Market, 2021 - 2033 (USD Million)
  • 7.6.4. UAE
    • 7.6.4.1. Key Country Dynamics
    • 7.6.4.2. Competitive Scenario
    • 7.6.4.3. Regulatory Framework
    • 7.6.4.4. UAE Small-Scale Bioreactors Market, 2021 - 2033 (USD Million)
  • 7.6.5. Kuwait
    • 7.6.5.1. Key Country Dynamics
    • 7.6.5.2. Competitive Scenario
    • 7.6.5.3. Regulatory Framework
    • 7.6.5.4. Kuwait Small-Scale Bioreactors Market, 2021 - 2033 (USD Million)

Chapter 8. Competitive Landscape

• 8.1. Company Categorization
• 8.2. Strategy Mapping
• 8.3. Company Profiles/Listing
  • 8.3.1. Sartorius AG
    • 8.3.1.1. Overview
    • 8.3.1.2. Financial Performance
    • 8.3.1.3. Product Benchmarking
    • 8.3.1.4. Strategic Initiatives
  • 8.3.2. Thermo Fisher Scientific Inc.
    • 8.3.2.1. Overview
    • 8.3.2.2. Financial Performance
    • 8.3.2.3. Product Benchmarking
    • 8.3.2.4. Strategic Initiatives
  • 8.3.3. Merck KGaA
    • 8.3.3.1. Overview
    • 8.3.3.2. Financial Performance
    • 8.3.3.3. Product Benchmarking
    • 8.3.3.4. Strategic Initiatives
  • 8.3.4. Danaher Corporation
    • 8.3.4.1. Overview
    • 8.3.4.2. Financial Performance
    • 8.3.4.3. Product Benchmarking
    • 8.3.4.4. Strategic Initiatives
  • 8.3.5. LAMBDA Instruments GmbH
    • 8.3.5.1. Overview
    • 8.3.5.2. Financial Performance
    • 8.3.5.3. Product Benchmarking
    • 8.3.5.4. Strategic Initiatives
  • 8.3.6. Solida Biotech GmbH
    • 8.3.6.1. Overview
    • 8.3.6.2. Financial Performance
    • 8.3.6.3. Product Benchmarking
    • 8.3.6.4. Strategic Initiatives
  • 8.3.7. Getinge AB
    • 8.3.7.1. Overview
    • 8.3.7.2. Financial Performance
    • 8.3.7.3. Product Benchmarking
    • 8.3.7.4. Strategic Initiatives
  • 8.3.8. DONALDSON ITALIA S.R.L (Solaris Biotechnology Srl)
    • 8.3.8.1. Overview
    • 8.3.8.2. Financial Performance
    • 8.3.8.3. Product Benchmarking
    • 8.3.8.4. Strategic Initiatives
  • 8.3.9. Eppendorf AG
    • 8.3.9.1. Overview
    • 8.3.9.2. Financial Performance
    • 8.3.9.3. Product Benchmarking
    • 8.3.9.4. Strategic Initiatives
  • 8.3.10. Infors AG
    • 8.3.10.1. Overview
    • 8.3.10.2. Financial Performance
    • 8.3.10.3. Product Benchmarking
    • 8.3.10.4. Strategic Initiatives